<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(9)</volume><submitter>Joubert IA</submitter><funding>National Health and Medical Research Council</funding><pubmed_abstract>Dual RNA-sequencing (dual RNA-seq) holds significant promise for deciphering bacterial virulence mechanisms during systemic infections. However, its application in sepsis research is hindered by technical challenges, including a low bacterial burden in blood and limited sample volumes and RNA yield from vulnerable populations, such as neonates. We developed an optimized protocol [dual RNA isolation from blood (DRIB)] for simultaneous stabilization, isolation and purification of high-quality host leukocyte and bacterial RNA from low-volume whole blood samples (0.5 ml). This protocol is compatible with clinical sample collection workflows and high-throughput RNA sequencing. The feasibility of DRIB for dual RNA-seq was validated using a pilot cohort of clinical adult sepsis samples, enabling </pubmed_abstract><journal>Microbial genomics</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12447629</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Dual RNA isolation from blood: an optimized protocol for host and bacterial RNA purification for dual RNA-sequencing analysis in whole blood sepsis samples.</pubmed_title><pmcid>PMC12447629</pmcid><funding_grant_id>APP1187809</funding_grant_id><funding_grant_id>2017081</funding_grant_id><pubmed_authors>Litton E</pubmed_authors><pubmed_authors>Wang P</pubmed_authors><pubmed_authors>Strunk T</pubmed_authors><pubmed_authors>Chopra A</pubmed_authors><pubmed_authors>Currie A</pubmed_authors><pubmed_authors>Raby E</pubmed_authors><pubmed_authors>Joubert IA</pubmed_authors><pubmed_authors>Mullally C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dual RNA isolation from blood: an optimized protocol for host and bacterial RNA purification for dual RNA-sequencing analysis in whole blood sepsis samples.</name><description>Dual RNA-sequencing (dual RNA-seq) holds significant promise for deciphering bacterial virulence mechanisms during systemic infections. However, its application in sepsis research is hindered by technical challenges, including a low bacterial burden in blood and limited sample volumes and RNA yield from vulnerable populations, such as neonates. We developed an optimized protocol [dual RNA isolation from blood (DRIB)] for simultaneous stabilization, isolation and purification of high-quality host leukocyte and bacterial RNA from low-volume whole blood samples (0.5 ml). This protocol is compatible with clinical sample collection workflows and high-throughput RNA sequencing. The feasibility of DRIB for dual RNA-seq was validated using a pilot cohort of clinical adult sepsis samples, enabling </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-03T17:29:55.269Z</modification><creation>2026-04-30T03:07:14.842Z</creation></dates><accession>S-EPMC12447629</accession><cross_references><pubmed>40965975</pubmed><doi>10.1099/mgen.0.001501</doi></cross_references></HashMap>